Table 1

Baseline clinical, sonographic and biomechanical features

Ultrasound guided steroid group (n=22)Unguided steroid group (n=22)Ultrasound guided placebo group (n=21)
Age, mean (SD) years49.0 (12.9)49.1 (10.7)50.1 (10.6)
Duration of symptoms, median (IQR) months6 (6–10)6 (5–11)7 (5–18)
BMI, mean (SD) kg/m230.7 (5.1)31.8 (5.0)32.4 (5.7)
Male sex, n (%)10 (45%)8 (36%)11 (52%)
Baseline plantar fascia thickness, mean (SD), mm6.1 (1.6)6.2 (1.4)5.8 (1.4)
Positive power Doppler signal, n (%)5 (23%)7 (32%)4 (19%)
Calcification, n (%)5 (23%)5 (23%)3 (14%)
Decreased echogenicity, n (%)12 (55%)7 (32%)8 (38%)
Pronated foot score >+6, n (%)17 (77%)13 (59)14 (67)
Supinated foot score <−1, n (%)2 (9%)0 (0%)1 (5%)
Baseline heel tenderness index, mean (SD)1.7 (0.8)2.0 (0.7)1.9 (0.7)
Baseline heel pain VAS score, mean (SD)62.0 (19.2)65.5 (19.6)56.0 (27.9)
  • BMI, body mass index; VAS, visual analogue score.